Current through the 2024 Regular Session
Section 73-21-119 - [Repealed Effective 7/1/2025] Labeling of drug products, biological products, and interchangeable biological products sold at retail(1) The label of the container of any drug product which is sold within the State of Mississippi for resale at retail and which requires a prescription to be dispensed at retail shall contain at a minimum the name of the manufacturer of the final dosage unit, expiration date if applicable, batch or lot number and national drug code. The label of the container of any biological product dispensed by a pharmacist shall include its nonproprietary name designated by the federal Food and Drug Administration for use and the name of the manufacturer of the product.(2) Whenever product selection is made, the pharmacist shall indicate on the label of the dispensed container the initials "G.E." or "I.B.," as appropriate. The label for generic equivalent drugs shall include the proprietary name of the product dispensed or the generic name of the product dispensed and its manufacturer either written in full or appropriately abbreviated, unless the prescriber indicates that the name of the drug product shall not appear on the label. The label for interchangeable biological products shall include its nonproprietary name designated by the federal Food and Drug Administration for use and the name of the manufacturer of the product.Laws, 1983, ch. 414, § 25; reenacted without change, Laws, 1991, ch. 527, § 25; reenacted without change, Laws, 1993, ch. 416, § 26; Laws, 1994, ch. 513, § 11; reenacted without change, Laws, 1998, ch. 511, § 27; reenacted without change, Laws, 2002, ch. 501, § 27; reenacted without change, Laws, 2006, ch. 533, § 26; reenacted without change, Laws, 2011, ch. 546, § 25, eff. 4/26/2011.Reenacted by Laws, 2020, ch. 419, HB 688,§ 27, eff. 7/1/2020.Amended by Laws, 2019, ch. 366, SB 2365,§ 3, eff. 7/1/2019.Reenacted by Laws, 2016, ch. 448, HB 462, 28, eff. 7/1/2016.